The page is the record's research on the issuer — no analyst, no rating, no view.

# Foghorn Therapeutics Inc. (NASDAQ: FHTX) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is Foghorn Therapeutics Inc., listed on NASDAQ under the ticker FHTX, with ISIN US3441741077. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, the jurisdiction is United States, Delaware, and the segment is not on the record. The issuer is listed and not halted.

## The disclosure read

The record holds 43 filings across 23 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 8.5 days, against 6.0 days for NASDAQ and 6.0 days for 2834 Pharmaceutical Preparations. The latest filing is dated 2026-10-05, a directors_dealings filing, which is 34 days before the record date of 2026-11-08. The median latency is 5.0 days for NASDAQ and 4.0 days for the sector. The median filings count is 52 for NASDAQ and 63.0 for the sector, and the issuer's filings by type are agm_egm 3, corporate_news 2, director_change 2, directors_dealings 21, prospectus 1, regulatory_filing 7, and results 7.

## Auditor

The auditor of record is Deloitte & Touche LLP, located in Boston, Massachusetts. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting, name change, or segment move lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.

## Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

No research houses were found on the issuer's investor-relations pages read. The count is 0.

## Open research

No openly published research notes were found on the record. The count is 0.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The record holds the issuer's sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

## Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001822462.json (identity.jurisdiction)
- https://mcp.us-cm-kg.ai/events/NASDAQ/FHTX (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/1822462/000162828026016814/fhtx-20251231.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NASDAQ/FHTX (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/FHTX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
